PLASMA EXCHANGE THERAPY (TPE) IN MYASTHENIC CRISIS PATIENTS
Keywords:
myasthenic crisisp, therapeutic plasma exchange (TPE), Myasthenic Crisis, Neuromuscular Disorders, Immunomodulatory TreatmentAbstract
Myasthenic crisis is an acute exacerbation of myasthenia gravis that results in weakness of the respiratory muscles, potentially leading to acute respiratory failure and the necessity for mechanical ventilation support. Approximately 15-20% of individuals with myasthenia gravis will experience a myasthenic crisis at some point in their lives, making it one of the most dangerous and life-threatening complications if not addressed promptly. Fortunately, mortality rates associated with myasthenic crises are currently decreasing, partly due to the effectiveness of therapeutic plasma exchange (TPE). TPE therapy works by removing pathological antibodies, immune complexes, and cytokines from the plasma and replacing them with replacement fluid. In this report, we discuss the case of a 61-year-old man with myasthenia gravis who was admitted to the emergency department (ED) and then to the intensive care unit (ICU) for one day due to a myasthenic crisis. He was intubated and received mechanical ventilation support, followed by plasma exchange therapy, which resulted in clinical improvement
Downloads
References
A.I. Qureshi, M.A. Choudhry, M.S. Akbar, Y. Mohammad, H.C. Chua, A.M. Yahia, J. A. Ulatowski, D.A. Krendel, R.T. Leshner, Plasma exchange versus intravenous immunoglobulin treatment in myasthenic crisis, Neurology, 52 (1999) 629–632, https://doi.org/10.1212/wnl.52.3.629.
Rapper AH, Samuels MA. Adams and Victor's Principles of Neurology Tenth Edition. Mc Graw Hill Medical. 2014;1470-83.
Wang, Y., Huan, X., Zhu, X., Song, J., Yan, C., Yang, L., Xi, C., Xu, Y., Xi, J., Zhao, C., Xia, R., Luo, S., 2024. Independent risk factors for in-hospital outcome of myasthenic crisis: a prospective cohort study. Ther. Adv. Neurol. Disord. 17, 61459463. https://doi.org/10.1177/17562864241226.
Jose America M, Fernandes S, Jose IS. Neurocritical care of myasthenic crisis in Myasthenia Gravis and Related Disorder. Switzerland. Springer Nature. 2018;12:189-197
Vernino S. Autoantibody Profiles and Neurological Correlations of Thymoma. Clinical Cancer Research. 2004;10(21):7270- 5.
Lacomis D. Myasthenic crisis. Neurocrit Care. 2005;03:189-194.
Wang, Y., Huan, X., Jiao, K., Jiang, Q., Goh, L.Y., Shi, J., Lv, Z., Xi, J., Song, J., Yan, C., Lin, J., Zhu, W., Zhu, X., Zhou, Z., Xia, R., Luo, S., Zhao, C., 2022. Plasma exchange versus intravenous immunoglobulin in AChR subtype myasthenic crisis: a prospective cohort study. Clin. Immunol. 241, 109058. https://doi.org/10.1016/j. clim.2022.109058.
N. Konig, H.R. Stetefeld, C. Dohmen, P. Mergenthaler, S. Kohler, S. Schonenberger, J. Bosel, D.H. Lee, S.T. Gerner, H.B. Huttner, H. Schneider, H. Reichmann, H. Fuhrer, B. Berger, J. Zinke, A. Alberty, I. Kleiter, C. Schneider-Gold, C. Roth, J. Dunkel, A. Steinbrecher, A. Thieme, F. Schlachetzki, R.A. Linker, K. Angstwurm, A. Meisel, B. Neumann, MuSK-antibodies are associated with worse outcome in myasthenic crisis requiring mechanical ventilation, J. Neurol. 268 (2021) 4824–4833, https://doi.org/10.1007/s00415-021-10603-9.
Farkas J. Myasthenia gravis & myasthenic crisis [Internet]. 2019 [cited 6 March 2019]. Available from: https://emcrit.org/ibcc/myasthenia/.
Nelke, C., Stascheit, F., Eckert, C., Pawlitzki, M., Schroeter, C.B., Huntemann, N., Mergenthaler, P., Arat, E., Ozturk, M., Foell, D., Schreiber, S., Vielhaber, S., Gassa, A., Stetefeld, H., Schroeter, M., Berger, B., Totzeck, A., Hagenacker, T., Meuth, S.G., Meisel, A., Wiendl, H., Ruck, T., 2022. Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients. J. Neuroinflammation 19, 89. https://doi.org/10.1186/s12974-022- 02448-4.
P. Mergenthaler, H.R. Stetefeld, C. Dohmen, S. Kohler, S. Schonenberger, J. Bosel, S.T. Gerner, H.B. Huttner, H. Schneider, H. Reichmann, H. Fuhrer, B. Berger, J. Zinke, A. Alberty, I. Kleiter, C. Schneider-Gold, C. Roth, J. Dunkel, A. Steinbrecher, A. Thieme, D.H. Lee, R.A. Linker, K. Angstwurm, A. Meisel, B. Neumann, Seronegative myasthenic crisis: a multicenter analysis, J. Neurol. (2022), https://doi.org/10.1007/s00415-022-11023-z.
Kaminski JH. Treatment of myasthenia gravis in Myasthenia gravis and related disorders, Current clinical neurology, Third edition. Springer Nature. 2018;168-81.
Claytor, B., Cho, S.M., Li, Y., 2023. Myasthenic crisis. Muscle Nerve 68, 8–19. https://doi.org/10.1002/mus.2783.
Pradian E, Mansjoer A, Maskoen T, Sugiarto A. Continuous Renal Replacement Theraphy (CRRT) and Plasmapheresis. 1st ed. Jakarta: PERDICI; 2018.
Hsu, C.W., Chen, N.C., Huang, W.C., Lin, H.C., Tsai, W.C., Huang, C.C., Cheng, B.C., Tsai, N.W., 2021. Hemogram parameters can predict in-hospital mortality of patients with Myasthenic crisis. BMC Neurol. 21, 388. https://doi.org/10.1186/s12883-021-02412-4 .
B. Neumann, K. Angstwurm, P. Mergenthaler, S. Kohler, S. Schonenberger, J. Bosel, U. Neumann, A. Vidal, H.B. Huttner, S.T. Gerner, A. Thieme, A. Steinbrecher, J. Dunkel, C. Roth, H. Schneider, E. Schimmel, H. Fuhrer, C. Fahrendorf, A. Alberty, J. Zinke, A. Meisel, C. Dohmen, H.R. Stetefeld, Myasthenic crisis demanding mechanical ventilation: a multicenter analysis of 250 cases, Neurology 94 (2020) e299–e313, https://doi.org/10.1212/WNL.0000000000008688.
X. Huan, S. Luo, H. Zhong, X. Zheng, J. Song, L. Zhou, J. Lu, Y. Wang, Y. Xu, J. Xi, Z. Zou, S. Chen, C. Zhao, In-depth peripheral CD4(+) T profile correlates with myasthenic crisis, Ann. Clin. Transl. Neurol. 8 (2021) 749–762, https://doi.org/10.1002/acn3.5131
Published
How to Cite
Issue
Section
Copyright (c) 2025 Reza Fazri Prasetyo, Bastian Lubis
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
.png)
